Clinical Trial Update: A Study of Famitinib in Patients With Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 study of famitinib in advanced colorectal cancer has completed. This update does not include trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Famitinib (Famitinib)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Colorectal Cancer, Colorectal Cancer Metastatic | Phase 2 | Status: COMPLETED